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Abstract
Purpose To evaluate the balance between existing evidence and expert opinions on the safety and efficacy of new techno-
logical improvements in lithotripsy techniques for percutaneous nephrolithotomy (PCNL).
Methods A scoping review approach was applied to search literature in Pubmed, Embase, and Web of Science. Consensus 
by key opinion leaders was reached at a 2-day meeting entitled “Consultation on Kidney Stones: Aspects of Intracorporeal 
Lithotripsy” held in Copenhagen, Denmark, in September 2019.
Results New-generation dual-mode single-probe lithotripsy devices have shown favourable results compared with use of 
ballistic or ultrasonic lithotripters only. However, ballistic and ultrasonic lithotripters are also highly effective and safe and 
have been the backbone of PCNL for many years. Compared with standard PCNL, it seems that mini PCNL is associated 
with fewer bleeding complications and shorter hospital admissions, but also with longer operating room (OR) time and higher 
intrarenal pressure. Use of laser lithotripsy combined with suction in mini PCNL is a promising alternative that may improve 
such PCNL by shortening OR times. Furthermore, supine PCNL is a good alternative, especially in cases with complex 
renal stones and large proximal ureteric stones; in addition, it facilitates endoscopic combined intrarenal surgery (ECIRS).
Conclusion Recent technological improvements in PCNL techniques are promising, but there is a lack of high-level evidence 
on safety and efficacy. Different techniques suit different types of stones and patients. The evolution of diverse methods has 
given urologists the possibility of a personalized stone approach, in other words, the right approach for the right patient.
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Introduction
Percutaneous nephrolithotomy (PCNL) was first described 
in 1976 by Fernström and Johansson as an operative tech-
nique for the removal of kidney stones through a percu-
taneous nephrostomy tract [1]. The approach was further 
developed in subsequent years, as illustrated by a case 
series published by Alken in 1981, which showed prom-
ising results in treatment of stones when using direct 
percutaneous ultrasound lithotripsy and stone extraction 
[2]. Further improvements in PCNL over the last decades 
have led to this method becoming one of the cornerstones 
in the treatment of large kidney stones, alongside shock 
wave lithotripsy (SWL) and retrograde intrarenal surgery 
(RIRS). In the EAU guidelines, PCNL is the standard pro-
cedure for large renal calculi (> 2 cm). The choice of endo-
scope, lithotripsy technique, and access tract size is made 
at the discretion of the surgeon and is not standardized [3]. 
The evolution of smaller tract sizes with the mini PCNL 
procedure and the effect of that approach on complica-
tion rates and stone-free rates (SFRs) are still not clear, 
and there is a scarcity of randomized controlled trials and 
high-quality research in this area.
To evaluate the balance between existing evidence, 
expert opinions, and the safety and efficacy of new techno-
logical improvements in lithotripsy in PCNL, key opinion 
leaders in the field were invited to evaluate and discuss the 
available evidence at a 2-day meeting entitled “Consulta-
tion on Kidney Stones: Aspects of Intracorporeal Litho-
tripsy “held in Copenhagen, Denmark, in September 2019. 
The experts were assigned different topics and prepared 
their presentations through scoping reviews achieved by 
scanning the literature using PubMed, EMBASE, and Web 
of Science. The first day of the meeting was open only to 
the experts, who first presented their topics for each other, 
after which the presentations were discussed within the 
group and were subsequently adjusted if necessary. The 
second day was open to a global audience, with all the 
experts giving their presentations, and this was followed 
by free discussions.
PCNL techniques
Conventional PCNL requires an access tract of 24–30F, 
and lithotripsy is traditionally performed using a rigid 
probe. The fragmentation device is usually ballistic, 
ultrasonic, or combined, although laser fragmentation 
has recently gained in popularity. Compared with the laser 
technique, ballistic and ultrasonic disintegration have the 
disadvantage of requiring straight access to the stone. Mini 
PCNL is usually classified as using tract sizes of 14–20F, 
and lithotripsy is generally performed by laser disintegra-
tion although other methods are possible [4]. Desai et al. 
described ultra-mini PCNL with an access tract of 11–13F 
using a 6F nephroscope; with this method only laser can 
be used for lithotripsy [4, 5]. Micro PCNL as reported 
by Desai in 2011 uses a 4.85F all-seeing needle with a 
16-gauge needle sheath and a three-way connector that 
allows irrigation and passage of a flexible telescope and a 
200-μm Holmium laser fibre [6].
Technical and safety aspects of ballistic, ultrasonic, 
and combined lithotripsy
Ballistic lithotripsy
Ballistic lithotripters use compressed air to accelerate a pro-
jectile inside the handpiece, which then hits the probe to 
elicit a shock wave that moves through the probe to the stone 
to cause mechanical fragmentation. This leads to significant 
retropulsion of the stone, and therefore, the stone must be 
pushed against the wall of the collecting system to optimize 
fragmentation and avoid loss of fragments. In most cases, 
both pressure and frequency can be altered on the device. 
The safety benefits of this technique are mainly associated 
with the absence of heat generation during lithotripsy, which 
means that there is no risk of thermal injury.
The Swiss  Lithoclast® (EMS) emerged in 1991 as the first 
available percutaneous ballistic lithotripsy device. A case 
series of 145 ureteroscopy (URS) procedures conducted by 
Yinghao et al. in 2000 resulted in stone-free rates (SFRs) 
of 55% after 1 month and 78% after 2 months [7]. All those 
procedures were performed with a rigid ureteroscope (9.5 
or 10.5F). In addition, secondary procedures such as SWL 
were common, and 3.4% had perforations of the ureter, the 
majority of which could be handled conservatively with 
stenting. The Cook LMA™ StoneBreaker™ is a ballistic 
lithotripter that offers the benefit of being portable, because 
it has self-contained  CO2 pressure cartridges. Each cartridge 
can deliver 80–100 shocks, and there is no need for an exter-
nal source of compressed air. In 2008, Nerli et al. published 
a prospective study of 110 patients undergoing URS with 
the StoneBreaker™ that showed promising results [8]. In 
that investigation, the mean stone size was 1.3 cm, and a 
mean of eight shocks was used for disintegration; no com-
plications were reported. In 2011, Chew et al. reported the 
results of the Canadian StoneBreaker trial, which was a ran-
domized controlled trial (RCT) comparing use of the LMA 
StoneBreaker™ and the Swiss  Lithoclast® during percuta-
neous nephrolithotripsy [9]. That assessment showed that 
the StoneBreaker™ provided faster stone fragmentation and 
total lithotripsy time, as well as shorter setup time, although 
there was no difference in SFR between these devices.
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Ultrasonic lithotripsy
Ultrasonic lithotripters use piezoceramic crystals that con-
vert electrical energy into mechanical energy, creating ultra-
sonic waves at 23–25 kHz. Acoustic waves from the hand-
piece cause the tip to vibrate, and fragmentation is achieved 
when the probe tip comes in contact with the stone. Probes 
are available from 2.5 to 6.0F. Ultrasonic probes are hollow 
and require continuous irrigation. The irrigation fluid and 
stone fragments are suctioned out through the probe, which 
has a cooling effect on the probe and the handpiece to pre-
vent overheating [10].
An RCT performed by Radfar et al. in 2017 compared 
the safety and efficacy of ultrasonic versus ballistic litho-
tripsy in PCNL [11]. No significant difference between the 
two techniques was found regarding SFRs or complications, 
but significantly shorter stone clearance time was observed 
when using ballistic lithotripsy for harder stones and ultra-
sonic lithotripsy for soft stones. Thus, it seems that these two 
probes have advantages for different stone types, leading to 
development of combination probes. Recently, the ultrasonic 
lithotripsy technology has been further developed to more 
precisely controlling probe vibration (UreTron). Initial expe-
rience with this device was tested in a non-randomized, pro-
spective comparison, and the Urotron lithotripter was found 
to achieve the highest stone clearance rate (59  mm2/min) in 
comparison to three state-of-art lithotripters (CyberWand™, 
StoneBreaker™, and Swiss LithoClast Select™) [12].
Two‑probe dual‑modality (ballistic and ultrasonic) 
lithotripsy
Dual-modality lithotripsy combines an ultrasonic device 
with a ballistic component to exploit the benefits of both 
devices and thereby improve the overall efficiency and 
versatility of lithotripsy. The CyberWand™ developed by 
Olympus is a dual ultrasonic/ballistic device with an inner 
hollow probe that vibrates at 21,000 Hz and a larger bal-
listic outer probe that moves at a lower frequency of 10 Hz. 
The two probes are connected to a single handpiece, and the 
inner probe can be activated alone or in conjunction with 
the outer probe. Direct contact with the stone is required for 
fragmentation.
The Swiss  Lithoclast® Master (EMS) is also a combined 
ultrasonic and ballistic lithotripter. The ballistic probe is 
positioned as a rod inside the hollow ultrasonic probe. The 
two modes, ultrasonic and ballistic, can be used individu-
ally or in combination. The basic principle of the Swiss 
 Lithoclast® Master is that the ultrasonic probe makes direct 
contact with the stone, and, when the ballistic probe is acti-
vated, the tip projects past the end of the ultrasonic probe 
and provides additional ballistic fragmentation. When the 
ballistic probe is retracted back within the ultrasonic probe, 
the ultrasonic fragmentation continues.
An RCT performed by Lehman et al. compared a com-
bined ultrasonic and ballistic lithotripter (Swiss  Lithoclast® 
Master) with a standard ultrasonic lithotripter in PCNL 
[13], and the results demonstrated that the dual mode was 
faster for fragmentation of hard stones but slower for soft 
stones, and there was no difference in OR time or SFRs. 
An in vitro study comparing the CyberWand™ and Swiss 
 Lithoclast® Master also showed a faster fragmentation time 
for the Cyberwand [14]. In a multicentre RCT comparing 
the CyberWand™ with a single probe ultrasonic lithotripter 
(Olympus LUS-II), Krambeck et al. found no difference in 
clinical outcomes, although the malfunction rate was higher 
with the CyberWand™ [15]. Another RCT conducted by 
York et al. compared the CyberWand™, Lithoclast Select 
(combination ballistic and ultrasonic device), and the Cook 
LMA™ StoneBreaker, and the different devices provided 
similar adjusted stone clearance rates for stones of > 2 cm 
and also offered comparable safety and efficacy [16].
Single‑probe dual‑modality (ballistic and ultrasonic) 
lithotripsy
The Olympus ShockPulse™, FDA approved in 2014, is a 
single-probe (2.91–11.3F) dual-action lithotripsy system that 
uses constant ultrasonic wave energy with intermittent bal-
listic shock wave energy. The device is controlled by buttons 
on the handpiece or by foot pedals, and the larger probes are 
hollow and equipped with a suction system. An in vitro study 
by Chew et al. compared the ShockPulse™ with the Cyber-
Wand™, Swiss  LithoClast® Master, and Olympus LUS-II 
[17]. The ShockPulse™ was faster than the LUS-II and 
Swiss  LithoClast® Master at both stone fragmentation and 
evacuation of the fragments. This can probably be explained 
by the fact that the lumen of ShockPulse™ is larger than 
the lumens of the two-probe combined devices, which are 
partly occupied by the ballistic/pneumatic probe. The same 
applies to the Swiss Lithoclast  Trilogy® (EMS), approved in 
2018, which has a single-probe (3.3–11.7F) design and uses 
ultrasonic and electromagnetic energy. This device applies 
suction through a hollow tube and has a foot pedal to con-
trol suction and lithotripsy. An in vitro study published by 
Carles et al. in 2018 showed that  Lithoclast® Trilogy had 
faster stone clearance time compared with ShockPulse™ and 
Swiss  Lithoclast® Select (Master) [18]. In a recent series 
comprising 31 cases, Swiss  Lithoclast® Trilogy was shown 
to be highly effective in both standard and mini PCNL, for 
which mean stone volume clearance ratios were 590.7 and 
370.5 mm3/min, respectively [19].
In an evaluation of tissue damage induced by differ-
ent lithotripter devices, Khoder et  al. compared Swiss 
 Lithoclast® Trilogy with two other ultrasound lithotripters 
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(Storz  Calcuson® and Swiss  LithoClast® Vario) [20]. The 
lithotripter probes were put in direct contact with bladder 
tissue from pigs for 10 s, and thereafter the histological fea-
tures were assessed. The authors found no significant differ-
ences between the tested devices with regard to histological 
findings, which indicates that the studied devices offered 
comparable safety. The handpiece of Swiss  Lithoclast® Tril-
ogy is significantly heavier than that of ShockPulse™, which 
may be important from the perspective of ergonomics. How-
ever, the impact of functional design on surgical outcome 
has not yet been sufficiently evaluated for the two combined 
lithotripters or for any other lithotripters.
Comparing clinical outcomes 
with conventional and miniaturized PCNL 
in the context of lithotripsy
Lithotripsy devices for miniaturized PCNL consist of lasers, 
ballistic and dual-modality lithotripters. Traditionally Hol-
mium lasers have been used, applying the so-called Vacuum 
Cleaner effect for fragment clearance [21]. Due to the fact 
that the probes of the dual-modality lithotripters have to be 
down-sized in miniaturized PCNL, there is a risk that frag-
ments will block the hollow probes. Recently, however, the 
Swiss  Lithoclast® Trilogy was found feasible even in mini 
PCNL due to optimized suction [22]. Although this suggests 
a role for dual-modality lithotripters in mini PCNL, further 
evaluation in comparative studies and clinical trials is war-
ranted. In the following lithotripsy data from clinical series 
in miniaturized PCNL will be discussed.
When comparing clinical outcomes between mini and 
standard PCNL, we specifically considered lithotripsy-
related outcomes such as SFRs, OR time, costs, and need for 
ancillary treatments. Karakan et al. conducted a randomized 
trial comparing ultra-mini PCNL (14F) with standard PCNL 
(26F) and found comparable SFRs for calculi of ≤ 2.5 cm 
[23]. In that study, lithotripsy was performed by holmium 
laser in the ultra-mini PCNL group, and ballistic litho-
tripsy energy was used for standard PCNL. SFR was 88% 
for standard PCNL compared with 89.3% for the ultra-mini 
PCNL, indicating similar efficiency for the two methods.
In a randomized study performed by Song et al., mini 
PCNL (16F) using laser and suction was assessed in com-
parison with combined ballistic and ultrasonic lithotripsy 
applied in standard PCNL [24]. The results showed that 
the mini PCNL technique was more efficient than standard 
PCNL after one procedure, with SFRs of 89% versus 58%. 
SFR was evaluated by plain abdominal radiography 3–5 days 
after surgery. The mini PCNL procedures with suction were 
also faster than the standard PCNLs. In another investiga-
tion, mini PCNL using laser disintegration was compared 
with standard PCNL using combined ballistic and ultrasonic 
lithotripsy for stones larger than 2 cm, and both techniques 
were found to be equally effective, regardless of whether the 
patients had a single stone or multiple calyceal stones [25].
Focusing specifically on staghorn calculi, Zhong et al. 
studied 54 patients who had such calculi and were rand-
omized to either mini PCNL or standard PCNL [26]. The 
data obtained showed that mini PCNL with multiple tracts 
was more effective than a standard PCNL with a single tract. 
In short, the mini PCNL had a higher SFR of 89.7% (com-
pared with 68% for standard PCNL) and was associated with 
fewer ancillary treatments.
In a meta-analysis including eight trials with a total 
of 749 patients, mini PCNL was compared with standard 
PCNL, and the authors found no difference in SFRs [27]. 
However, the mini PCNL patients had shorter hospital stays 
and fewer blood transfusions than the patients in the stand-
ard group. On the other hand, OR time was longer for mini 
PCNL than for standard PCNL.
The efficacy of mini PCNL for larger stones has been 
debated. Kokov et al. reported the SFR to be 42.5% after 
mini PCNL, where stone size was the only independent risk 
factor for residual fragments [28]. In a systematic review 
on the efficacy and safety of mini PCNL published by the 
European Association of Urology Urolithiasis Guidelines 
Panel in 2017, it was concluded that available studies do 
suggest that mini PCNL is at least as efficient as standard 
PCNL [29]. However, only two RCTs were included in that 
review, and those trials differed with regard to the tract sizes 
used and the type of stones treated [30, 31]. In another RCT, 
Ganesamoni et al. compared ballistic lithotripsy with laser 
lithotripsy in mini PCNL and found that the former approach 
created larger fragments and more stone migration, and also 
required more stone retrieval, whereas the two approaches 
did not differ with respect to fragmentation time and SFR 
[32].
Overall, there are severe problems when trying to draw 
conclusions about clinical outcomes of PCNL from differ-
ent studies. On the one hand, there is a lack of high-quality 
RCTs, and retrospective studies are often flawed by selec-
tion bias. On the other hand, the heterogenous nature of 
stone disease makes it very difficult to perform meaningful 
RCTs, because such studies typically include very selec-
tive cases that do not necessarily reflect daily clinical prac-
tice. Furthermore, surgeons have their preferences and so 
do patients, which means that it is not always possible to 
translate the results of RCTs into local clinical practice. In 
addition, differences in the techniques used, tract size, stone 
size and complexity, definitions of SFR, modality of defin-
ing SFR (US/KUB/CT) and the time point at which SFR 
is evaluated are often not reported in a uniform manner, 
which makes comparisons problematic. From this perspec-
tive, evidence-based medicine (EBM) with regard to aspects 
of lithotripsy in PCNL will to a large extent have to rely 
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on clinical expertise and patient’s preference, values, and 
expectations rather than on high-level scientific evidence 
(Fig. 1). With a lack of high-level evidence supporting dif-
ferent lithotripsy techniques, it is especially important to 
consider safety aspects of newer approaches such as min-
iaturized PCNL.
Safety aspects of lithotripsy during miniaturized 
PCNL
To perform PCNL safely, it is necessary to have appropriate 
endoscopic vision, cooling of the lithotripsy environment to 
prevent overheating, and sufficient expansion of the collect-
ing system for atraumatic movements. There is also a need 
for a safe way to evacuate stone fragments effectively in 
mini PCNL. Maintaining control over intrarenal pressure is 
important as well, because there is evidence that high intra-
renal pressure during PCNL increases the risk of postopera-
tive morbidity [33, 34]. Furthermore, a rise in such pressure 
may cause reduced renal blood flow, pyelovenous backflow, 
and pyelolymphatic backflow, which may potentially cause 
infectious and bleeding-related complications [34]. In addi-
tion, increase in intrarenal pressure leads to extravasation of 
fluid, potentially leading to postoperative pain. Clearly, the 
risks and morbidity of intrarenal reflux, pelvic perforation, 
thermal injury, and serious infectious and bleeding compli-
cations need to be thoroughly evaluated and compared with 
standard PCNL.
There are concerns that mini PCNL may cause higher 
intrarenal pressures due to less efficient drainage of irri-
gation fluid. A study by Tepeler et al. found significantly 
higher intrarenal pressure in mini PCNL procedures than in 
standard PCNLs, although outcomes in both were similar 
in terms of complications and stone clearance [31]. Omar 
et al. evaluated the impact of irrigation pressures in standard 
PCNL on risk of systemic inflammatory response syndrome 
(SIRS) and observed that high-pressure fluid irrigation was 
a risk factor for postoperative SIRS [35]. Chu et al. focused 
specifically on the differences between standard and mini 
PCNL and found comparatively higher intrarenal pressures 
for mini PCNL, and also noted that mini PCNL procedures 
were more likely to be associated with postoperative sepsis 
[36]. In a porcine model, mini PCNL was associated with 
higher intrarenal pressures and higher risk of organ bacte-
rial seeding in the setting of an infected collecting system, 
suggesting a higher potential for infectious complications 
[37]. Suction through the sheath or other intrarenal pressure-
regulating systems (e.g., new designs of the sheath) may 
overcome the concerns regarding pressure in mini PCNL, 
and suction through the sheath during miniaturized PCNL 
definitely deserves attention with respect to both efficacy 
and safety [38–40].
Lithotripsy and stone clearance in supine PCNL
There are no guidelines for the use of supine or prone PCNL, 
and the existing evidence in this area is limited primarily to 
sparse expert opinions. In supine PCNL, the nephroscope is 
inserted from below through a horizontal or slightly down-
ward inclined Amplatz sheath. This angle uses gravity to 
drain the irrigation fluid and the stone fragments. Accord-
ingly, the collecting system is less distended, and the intra-
renal pressure may be lower than in the prone position, 
which may cause reduced vision and working space but 
potentially reduces the risk of postoperative infection [41, 
42]. Despite the plausibly lower intrarenal pressure in supine 
PCNL, it is possible that fragments can descend into the 
ureter more easily than in the prone position due to gravita-
tional effects. However, in endoscopic combined intrarenal 
surgery (ECIRS) this is not a problem, because a flexible 
ureteroscope is positioned in the ureter, both to occupy that 
position and to detect fragments that might drain into the 
ureter [43, 44].
ECIRS has several benefits, especially for larger stones 
that might otherwise require multiple access tracts or a two-
step procedure to attain complete stone fragmentation. Using 
only one percutaneous access tract in a one-step PCNL, in 
combination with flexible ureteroscopy, it is possible to 
minimize morbidity without sacrificing the quality of stone 
fragmentation or clearance of complex stones [45]. The flex-
ible ureteroscope contributes in a multitude of ways: it has 
a preliminary diagnostic and intraoperative role helping in 
real-time procedural choices; it can reach calyces that are 
difficult or even impossible to reach with a rigid nephro-
scope; it actively contributes to achieving endoscopic vision 
and to stone fragmentation and reduces radiation exposure; 
it is also helpful at the end of the operation to evaluate the Fig. 1  Approach to individualized stone treatment
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calyceal system for residual fragments [46]. An additional 
benefit of ECIRS is that a stone in a calyx awkward for RIRS 
may be passed to the nephroscope for stone fragmentation 
(‘passing the ball’).
ECIRS in the Galdakao-modified supine Valdivia 
(GMSV) position has also been shown to offer good results 
in the treatment of impacted proximal ureteral stones [43]. 
The use of a combined approach creates an open, low-pres-
sure system that reduces the absorption of irrigation fluid 
into the circulation [47]. This makes it possible to push the 
stone/stone fragments up into the renal pelvis and subse-
quently remove them via the percutaneous access. This in 
turn reduces the risk of ureteral injury that is associated with 
lithotripsy and stone basketing.
In a meta-analysis of 15 RCTs with a total of 1474 
patients, Lie et al. compared supine versus prone position 
in PCNL and found that operative time in supine PCNL was 
shorter [48]. As also mentioned above, Lie and colleagues 
noted that the downward or horizontal angle of the Amplatz 
sheath facilitated faster evacuation of stone fragments with 
the help of gravity. Furthermore, these investigators found 
lower rates of postoperative fever in the supine group than in 
the prone group, which confirms data from the large CROES 
PCNL study [49].
Conclusion
Today, PCNL is not standardized in terms of technical 
considerations such as access tract size and devices used 
for stone disintegration. Standard PCNL (24–30F) enables 
the use of probes that make it possible for fragments to 
be both disintegrated and removed by suction through the 
same probe. Older devices that rely purely on ballistic or 
ultrasonic techniques are still viable and have proven their 
efficacy and safety over many years. New technological 
advances including single-probe dual-modality lithotripters 
using a combination of ultrasonic and ballistic techniques 
are promising, and seem to be more effective than single-
energy probes. Mini PCNL requires smaller probes for lith-
otripsy, and larger fragments cannot be extracted through 
the probe. However, small fragments resulting from laser 
lithotripsy can be effectively evacuated using the vacuum 
cleaner effect [21, 50]. New developments such as the use of 
laser lithotripsy in combination with suction devices in mini 
PCNL appear to be safe and effective, and may even further 
increase the efficacy and safety of mini PCNL. Moreover, 
laser probes are flexible and can be used in flexible endo-
scopic devices. There is limited quality evidence comparing 
standard and mini PCNL, although research has indicated 
that mini PCNL is associated with fewer bleeding compli-
cations and shorter hospital admissions [27]. However, a 
drawback of mini PCNL is that it apparently requires longer 
OR time [27]. On the other hand, the use of laser lithotripsy 
combined with suction may be a promising alternative that 
can potentially improve mini PCNL performance by shorten-
ing OR times [23, 24].
In that context, using supine positioning of patients dur-
ing PCNL is a good alternative, especially in complex renal 
stone situations that require a combined approach (i.e., 
ECIRS). However, there is no evidence that one method is 
better than the other, such as standard PCNL with ballistic 
and/or ultrasonic disintegration or mini PCNL with laser dis-
integration. However, the evolution of different techniques 
has increased the possibilities of a personalized approach, in 
other words, the right method for the right patient.
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